IndraLab

Statements


| 3

sparser
"Usp18 can directly activate the JAK/STAT signaling pathway to promote IFN responses [ xref ] or may bind to interferon receptor 2 (IFNAR2) and inhibit the JAK/STAT [ xref ]."

sparser
"Interestingly, USP18 in humans (but not in mice) can also interfere with the anti-viral outcome of IFN signaling by an additional mechanism: USP18 can bind the interferon receptor 2 (IFNAR2), block the association of JAK, and possibly limit IFNAR2-IFNAR1 dimerization, thereby interfering with the JAK-STAT signaling pathway xref ."

sparser
"Their study showed that USP18 does not interact with IFNAR1, but with Box1-Box2 region of IFNAR2 to disrupt its interaction with JAK to inhibit JAK’s tyrosine kinase activity in a DUB activity independent manner [ xref ]."